Nicotinamide riboside for Peripheral Nervous System Diseases
This study is evaluating whether nicotinamide riboside may help improve neuropathy in cancer survivors.
See full descriptionAbout the trial for Peripheral Nervous System Diseases
Treatment Groups
This trial involves 2 different treatments. Nicotinamide Riboside is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.
About The Treatment
Eligibility
This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Nicotinamide riboside will improve 2 primary outcomes and 3 secondary outcomes in patients with Peripheral Nervous System Diseases. Measurement will happen over the course of 84 days.
Patient Q & A Section
How many people get peripheral nervous system diseases a year in the United States?
The American Cancer Society estimates that 2,100 cases of peripheral nerve neuropathy will be noticed in people over the age of 20 a year in the United States.
What are the signs of peripheral nervous system diseases?
Symptoms such as painless paresthesia, burning sensation and itching and muscle weakness may suggest disorders of peripheral nervous system. The differential diagnosis should be considered while a patient presents with neuropathic symptoms in the context of a systemic disease with involvement of nervous system. The signs of peripheral nervous system disease are often subtle and may be missed easily. It is prudent for clinicians to keep a list of possible causes for patients presenting with neuropathic symptoms. They may include trauma, surgery, systemic diseases, malignancy, chronic infection, vasculitis, Behçet's disease, drug toxicity, multiple sclerosis, amyloidosis, neurogastroenteropathy and neuromuscular disorders.
What is peripheral nervous system diseases?
The word 'phrenic' means 'of the nerves'. The word 'peripheral' comes from the Greek περι ('peri' 'around') and ᾤφηρες ('phèrès' 'nerves'), so that 'the nerves of the peripheral nervous system'.\n
What causes peripheral nervous system diseases?
Peripheral nervous system diseases can arise due to any disease. Though peripheral neuropathy is not contagious, it is more common in some people with a disease such as diabetes, or alcoholism. If the disease is untreated it can become symptomatic. Prevention includes health education and smoking control.\n
Can peripheral nervous system diseases be cured?
All chronic central or peripheral PNMDs can be cured by conservative treatment. Patients with chronic PNMD who suffer disabling pain resulting in limited activities of daily living may not improve if they were first treated with medication or surgical procedures that do not restore normal sensation.
What are common treatments for peripheral nervous system diseases?
A significant portion of people with PN have [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain). In addition, neuropathic pain, headache, and chronic migraines are common diagnoses of PN. Although treatment for PN often includes a variety of drugs and medical procedures, such as tricyclic antidepressants and anticonvulsants, these often lead to only a limited benefit in terms of pain control.
How serious can peripheral nervous system diseases be?
Results from a recent clinical trial showed that when doctors treat PNS diseases, there is a concern for the probability of severe complications that make it necessary to perform a decompression operation prior to the treatment of most patients. If the patient has a decompression disorder, but still has no neurological deterioration, it is very unlikely that the condition will be life-threatening. If neurological deterioration has occurred in the past, these patients should be monitored with a high index of suspicion and prompt decompression of the nervous system.
What is the primary cause of peripheral nervous system diseases?
The diagnosis of central and peripheral nervous system diseases were determined mostly by referral bases rather than by formal diagnostic criteria set by researchers. Patients with both central and peripheral nervous system disease were more likely to have multiple diagnoses.
Is nicotinamide riboside typically used in combination with any other treatments?
Nucleoside analogues are often prescribed as adjuvant treatment in patients with NBSCC. There is low patient compliance rates and low overall clinical outcomes in the real-world patient population. Nucleoside analogues are used with other anticancer therapy, such as bleomycin, taxanes (paclitaxel), or capecitabine to improve outcomes. However, there are few randomized trial data to guide treatment strategy. Nicotinamide riboside has not been studied in any randomized trials. This article is open-access; it is available to all. ClinicalTrials.gov registered protocols: NCT00241361 and NCT00241362.
What does nicotinamide riboside usually treat?
In a recent study, findings suggest that it might be reasonable to consider NAM as an alternative to the conventional treatment of patients with high-risk PN.
What is the latest research for peripheral nervous system diseases?
Most recent scientific information deals only with general management, but is mainly anecdotal. Most research in this area is based at small-scale clinical studies, and the results are very variable depending on the disease and medical treatment studied. In particular, the evidence regarding the long-term outcome of children with Spina bifida is lacking, and further studies comparing surgical approaches to nonsurgical approaches of Spina bifida repair are needed. This knowledge would facilitate better patient counselling and support during treatments and following the disease development.
What is the average age someone gets peripheral nervous system diseases?
Nervous system diseases account for an increasing number of patients seen in all medical specialties. More than half of patients with Nervous System Disorders require hospitalization and a third of patients are on non-clinical therapies. In the US, these diseases affect both males and females. Age is a risk factor for all types of peripheral nervous system disease; however, it has been reported that Nervous System Disorders are the greatest risk factor for children and females of a given age. Other factors may include lifestyle, race, family history of disease, and genetics. The most common forms of peripheral nervous system disorders are diabetic neuropathy or peripheral neuropathy and Guillain-Aarrhum syndrome.